Ascendis Pharma A/S
ASND173.500USD
+6.720+4.03%
收盘 07/31, 16:00（美东）报价延迟15分钟
10.58B总市值
亏损市盈率 TTM
关于 Ascendis Pharma A/S 公司
Ascendis Pharma A/S 是一家总部位于丹麦的制药产品生产公司。该公司生产的产品用于治疗生长激素缺乏症、内分泌学、中枢神经系统疾病、传染病和糖尿病。该公司通过其子公司在全球开展业务：Ascendis Pharma GmbH（德国）、Ascendis Pharma, Inc.（美国特拉华州）、Ascendis Pharma Endocrinology, Inc.（美国特拉华州）、Ascendis Pharma, Ophthalmology Division A/S（丹麦）、Ascendis Pharma, Endocrinology Division A/S（丹麦）、Ascendis Pharma Bone Diseases A/S（丹麦）、Ascendis Pharma Growth Disorders A/S（丹麦）和 Ascendis Pharma Oncology Division A/S（丹麦）。
公司简介
公司代码ASND
公司名称Ascendis Pharma A/S
上市日期Jan 28, 2015
成立日期2006
CEOMr. Jan Moller Mikkelsen
员工数量- -
证券类型Depository Receipt
年结日Jan 28
公司地址Tuborg Boulevard 12
城市HELLERUP
上市交易所NASDAQ Global Select Consolidated
国家Denmark
邮编2900
电话4570222244
网址https://ascendispharma.dk/
公司代码ASND
上市日期Jan 28, 2015
成立日期2006
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
--
Mr. Donovan (Jay) Wu
Mr. Donovan (Jay) Wu
Executive Vice President, U.S. President
Executive Vice President, U.S. President
--
--
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
收入明细
单位: EUR更新时间: 7月6日 周日
单位: EUR更新时间: 7月6日 周日
FY2025Q1
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务EUR
名称
营收
占比
Commercial sale of products
96.03M
95.12%
Rendering of services
3.52M
3.49%
License
1.40M
1.39%
地区EUR
名称
营收
占比
North America
73.69M
72.99%
Europe
21.33M
21.13%
Rest of world
5.94M
5.88%
业务
地区
业务EUR
名称
营收
占比
Commercial sale of products
96.03M
95.12%
Rendering of services
3.52M
3.49%
License
1.40M
1.39%
股东统计
更新时间: 7月23日 周三
更新时间: 7月23日 周三
持股股东
股东类型
持股股东
持股股东
占比
RA Capital Management, LP
17.03%
Westfield Capital Management Company, L.P.
9.08%
Avoro Capital Advisors LLC
8.64%
Janus Henderson Investors
7.43%
Fidelity Management & Research Company LLC
7.13%
Other
50.69%
持股股东
持股股东
占比
RA Capital Management, LP
17.03%
Westfield Capital Management Company, L.P.
9.08%
Avoro Capital Advisors LLC
8.64%
Janus Henderson Investors
7.43%
Fidelity Management & Research Company LLC
7.13%
Other
50.69%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
41.95%
Investment Advisor
39.67%
Venture Capital
17.38%
Hedge Fund
8.82%
Research Firm
4.70%
Individual Investor
0.78%
Family Office
0.44%
Family Office
0.44%
Pension Fund
0.36%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
499
70.49M
116.76%
-1.46M
2025Q1
513
68.89M
114.10%
-3.55M
2024Q4
488
67.37M
111.00%
-7.76M
2024Q3
475
65.25M
107.66%
-6.23M
2024Q2
459
63.44M
108.94%
-9.21M
2024Q1
453
63.54M
109.13%
-8.68M
2023Q4
430
62.90M
109.00%
-9.55M
2023Q3
414
62.85M
109.61%
-11.90M
2023Q2
426
63.03M
109.93%
-13.27M
2023Q1
427
63.10M
110.08%
-9.14M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RA Capital Management, LP
10.28M
17.03%
+168.75K
+1.67%
Mar 31, 2025
Westfield Capital Management Company, L.P.
5.48M
9.08%
-48.98K
-0.89%
Mar 31, 2025
Avoro Capital Advisors LLC
5.22M
8.64%
+114.94K
+2.25%
Mar 31, 2025
Janus Henderson Investors
4.49M
7.43%
+106.57K
+2.43%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.30M
7.13%
-52.57K
-1.21%
Mar 31, 2025
Artisan Partners Limited Partnership
4.26M
7.05%
-193.79K
-4.35%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
3.05M
5.06%
+328.28K
+12.04%
Mar 31, 2025
Capital International Investors
2.87M
4.76%
+11.54K
+0.40%
Mar 31, 2025
T. Rowe Price Associates, Inc.
2.26M
3.74%
-27.11K
-1.19%
Mar 31, 2025
MFS Investment Management
1.87M
3.1%
+9.63K
+0.52%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
Harbor Health Care ETF
18.34%
AdvisorShares Dorsey Wright ADR ETF
2.58%
American Century Focused Dynamic Growth ETF
2.27%
BNY Mellon Innovators ETF
2.26%
Virtus LifeSci Biotech Products ETF
2.01%
Tema Heart & Health ETF
1.25%
ProShares Ultra Nasdaq Biotechnology
1.19%
Invesco Nasdaq Biotechnology ETF
1.11%
Main Thematic Innovation ETF
0.76%
Putnam Sustainable Future ETF
0.75%
查看更多
Harbor Health Care ETF
占比18.34%
AdvisorShares Dorsey Wright ADR ETF
占比2.58%
American Century Focused Dynamic Growth ETF
占比2.27%
BNY Mellon Innovators ETF
占比2.26%
Virtus LifeSci Biotech Products ETF
占比2.01%
Tema Heart & Health ETF
占比1.25%
ProShares Ultra Nasdaq Biotechnology
占比1.19%
Invesco Nasdaq Biotechnology ETF
占比1.11%
Main Thematic Innovation ETF
占比0.76%
Putnam Sustainable Future ETF
占比0.75%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
